Name: SGNLV-005
Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for unresectable locally advanced metastatic solid tumours.
Study Coordinator: Bronwyn Raymond
Status: Closed
Condition: Head and Neck Cancer
More information about SGNLV-005
More information
For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see:
Research and Clinical Trials